118 related articles for article (PubMed ID: 23118213)
1. Transcription factor dose links development to disease.
Sigvardsson M
Blood; 2012 Nov; 120(18):3630-1. PubMed ID: 23118213
[No Abstract] [Full Text] [Related]
2. Biphenotypic B-lymphoid/myeloid cells expressing low levels of Pax5: potential targets of BAL development.
Simmons S; Knoll M; Drewell C; Wolf I; Mollenkopf HJ; Bouquet C; Melchers F
Blood; 2012 Nov; 120(18):3688-98. PubMed ID: 22927250
[TBL] [Abstract][Full Text] [Related]
3. Losing B cell identity.
Carotta S; Nutt SL
Bioessays; 2008 Mar; 30(3):203-7. PubMed ID: 18293359
[TBL] [Abstract][Full Text] [Related]
4. Pax5 loss imposes a reversible differentiation block in B-progenitor acute lymphoblastic leukemia.
Liu GJ; Cimmino L; Jude JG; Hu Y; Witkowski MT; McKenzie MD; Kartal-Kaess M; Best SA; Tuohey L; Liao Y; Shi W; Mullighan CG; Farrar MA; Nutt SL; Smyth GK; Zuber J; Dickins RA
Genes Dev; 2014 Jun; 28(12):1337-50. PubMed ID: 24939936
[TBL] [Abstract][Full Text] [Related]
5. Expression profiling of transcription factors in B- or T-acute lymphoblastic leukemia/lymphoma and burkitt lymphoma: usefulness of PAX5 immunostaining as pan-Pre-B-cell marker.
Nasr MR; Rosenthal N; Syrbu S
Am J Clin Pathol; 2010 Jan; 133(1):41-8. PubMed ID: 20023257
[TBL] [Abstract][Full Text] [Related]
6. Reprogramming of B cells.
Cobaleda C
Methods Mol Biol; 2010; 636():233-50. PubMed ID: 20336527
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of precursor B-cell malignancy progression by toll-like receptor ligand-induced immune responses.
Fidanza M; Seif AE; DeMicco A; Rolf N; Jo S; Yin B; Li Y; Barrett DM; Duque-Afonso J; Cleary ML; Bassing CH; Grupp SA; Reid GS
Leukemia; 2016 Oct; 30(10):2116-2119. PubMed ID: 27220664
[No Abstract] [Full Text] [Related]
8. Paired box gene 5 isoforms A and B have different functions in transcriptional regulation of B cell development-related genes in immature B cells.
Kikuchi H; Nakayama M; Kuribayashi F; Mimuro H; Imajoh-Ohmi S; Nishitoh H; Takami Y; Nakayama T
Microbiol Immunol; 2015 Jul; 59(7):426-31. PubMed ID: 26094714
[TBL] [Abstract][Full Text] [Related]
9. Expression and production of aberrant PAX5 with deletion of exon 8 in B-lineage acute lymphoblastic leukaemia of children.
Sadakane Y; Zaitsu M; Nishi M; Sugita K; Mizutani S; Matsuzaki A; Sueoka E; Hamasaki Y; Ishii E
Br J Haematol; 2007 Jan; 136(2):297-300. PubMed ID: 17129225
[TBL] [Abstract][Full Text] [Related]
10. PAX5 is a tumor suppressor in mouse mutagenesis models of acute lymphoblastic leukemia.
Dang J; Wei L; de Ridder J; Su X; Rust AG; Roberts KG; Payne-Turner D; Cheng J; Ma J; Qu C; Wu G; Song G; Huether RG; Schulman B; Janke L; Zhang J; Downing JR; van der Weyden L; Adams DJ; Mullighan CG
Blood; 2015 Jun; 125(23):3609-17. PubMed ID: 25855603
[TBL] [Abstract][Full Text] [Related]
11. B-cell identity--commitment is not forever.
Nutt SL
N Engl J Med; 2008 Jan; 358(1):82-3. PubMed ID: 18172181
[No Abstract] [Full Text] [Related]
12. Comparative genomics reveals multistep pathogenesis of E2A-PBX1 acute lymphoblastic leukemia.
Duque-Afonso J; Feng J; Scherer F; Lin CH; Wong SH; Wang Z; Iwasaki M; Cleary ML
J Clin Invest; 2015 Sep; 125(9):3667-80. PubMed ID: 26301816
[TBL] [Abstract][Full Text] [Related]
13. Pax5 maintains cellular identity by repressing gene expression throughout B cell differentiation.
Carotta S; Holmes ML; Pridans C; Nutt SL
Cell Cycle; 2006 Nov; 5(21):2452-6. PubMed ID: 17102626
[TBL] [Abstract][Full Text] [Related]
14. Transcription-factor-mediated supervision of global genome architecture maintains B cell identity.
Johanson TM; Lun ATL; Coughlan HD; Tan T; Smyth GK; Nutt SL; Allan RS
Nat Immunol; 2018 Nov; 19(11):1257-1264. PubMed ID: 30323344
[TBL] [Abstract][Full Text] [Related]
15. [B/T-cell biphenotypic lymphoblastic lymphoma/leukemia: report of a case].
Chen DB; Wang Y; Dai L
Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):704-5. PubMed ID: 24433739
[No Abstract] [Full Text] [Related]
16. PAX5 promotes pre-B cell proliferation by regulating the expression of pre-B cell receptor and its downstream signaling.
Xue K; Song J; Yang Y; Li Z; Wu C; Jin J; Li W
Mol Immunol; 2016 May; 73():1-9. PubMed ID: 27016671
[TBL] [Abstract][Full Text] [Related]
17. PAX5 is part of a functional transcription factor network targeted in lymphoid leukemia.
Okuyama K; Strid T; Kuruvilla J; Somasundaram R; Cristobal S; Smith E; Prasad M; Fioretos T; Lilljebjörn H; Soneji S; Lang S; Ungerbäck J; Sigvardsson M
PLoS Genet; 2019 Aug; 15(8):e1008280. PubMed ID: 31381561
[TBL] [Abstract][Full Text] [Related]
18. Early B cell factor: Regulator of B lineage specification and commitment.
Lukin K; Fields S; Hartley J; Hagman J
Semin Immunol; 2008 Aug; 20(4):221-7. PubMed ID: 18722139
[TBL] [Abstract][Full Text] [Related]
19. Interactions between lineage-associated transcription factors govern haematopoietic progenitor states.
Kucinski I; Wilson NK; Hannah R; Kinston SJ; Cauchy P; Lenaerts A; Grosschedl R; Göttgens B
EMBO J; 2020 Dec; 39(24):e104983. PubMed ID: 33103827
[TBL] [Abstract][Full Text] [Related]
20. Pax5: a master regulator of B cell development and leukemogenesis.
Medvedovic J; Ebert A; Tagoh H; Busslinger M
Adv Immunol; 2011; 111():179-206. PubMed ID: 21970955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
